High-Density Lipoprotein Changes in Alzheimer’s Disease Are APOE Genotype-Specific
Authors:
- Brian V. HongBrian V. Hong
- Jingyuan ZhengJZJingyuan Zheng
- Joanne K. AgusJAJoanne K. Agus
- Xinyu TangXTXinyu Tang
- Carlito B. LebrillaCLCarlito B. Lebrilla
- Lee-Way JinLJLee-Way Jin
- Izumi MaezawaIMIzumi Maezawa
- Kelsey EricksonKEKelsey Erickson
- Danielle J. HarveyDHDanielle J. Harvey
- Charles S. DeCarliCDCharles S. DeCarli
- Dan M. MungasDMDan M. Mungas
- John M. OlichneyJOJohn M. Olichney
Open Access
- 24 June 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (7) , 1495
Abstract
High-density lipoproteins (HDL) play a critical role in cholesterol homeostasis. Apolipoprotein E (APOE), particularly the E4 allele, is a significant risk factor for Alzheimer’s disease but is also a key HDL-associated protein involved in lipid transport in both the periphery and central nervous systems. The objective was to determine the influence of the APOE genotype on HDL function and size in the context of Alzheimer’s disease. HDL from 194 participants (non-demented controls, mild cognitive impairment, and Alzheimer’s disease dementia) were isolated from the plasma. The HDL cholesterol efflux capacity (CEC), lecithin-cholesterol acyltransferase (LCAT) activity, and particle diameter were measured. Neuropsychological test scores, clinical dementia rating, and magnetic resonance imaging scores were used to determine if cognition is associated with HDL function and size. HDL CEC and LCAT activity were reduced in APOE3E4 carriers compared to APOE3E3 carriers, regardless of diagnosis. In APOE3E3 carriers, CEC and LCAT activity were lower in patients. In APOE3E4 patients, the average particle size was lower. HDL LCAT activity and particle size were positively correlated with the neuropsychological scores and negatively correlated with the clinical dementia rating. We provide evidence for the first time of APOE genotype-specific alterations in HDL particles in Alzheimer’s disease and an association between HDL function, size, and cognitive function.Keywords
Funding Information
- National Institutes of Health (R01AG062240, P30AG072972, CA-D-NUT-2242-H)
- UC Davis Alzheimer’s Disease Research Center (R01AG062240, P30AG072972, CA-D-NUT-2242-H)
- USDA National Institute of Food and Agriculture Hatch Fund Project (R01AG062240, P30AG072972, CA-D-NUT-2242-H)
This publication has 45 references indexed in Scilit:
- Aging affects high-density lipoprotein composition and functionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer DiseaseJournal of Biological Chemistry, 2010
- Recruitment of a Community-based Cohort for Research on Diversity and Risk of DementiaAlzheimer Disease & Associated Disorders, 2010
- Predicting the time of conversion to MCI in the elderlyNeurology, 2009
- Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein ClustersArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-IProceedings of the National Academy of Sciences, 2008
- Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆Neurobiology of Aging, 2000